Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis
Authors
Keywords
Coronary artery disease, Diabetes, Meta-analysis, Systemic review
Journal
Cardiovascular Diabetology
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-30
DOI
10.1186/s12933-019-0900-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin Use and Kidney Cancer Survival Outcomes
- (2019) Madhur Nayan et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Metformin Protects the Heart Against Hypertrophic and Apoptotic Remodeling After Myocardial Infarction
- (2019) Halyna Loi et al. Frontiers in Pharmacology
- Metformin was associated with lower all-cause mortality in type 2 diabetes with acute coronary syndrome: A Nationwide registry with propensity score-matched analysis
- (2019) Chien-Boon Jong et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease
- (2019) David M. Charytan et al. DIABETES OBESITY & METABOLISM
- Cardioprotection by Metformin: Beneficial Effects Beyond Glucose Reduction
- (2018) Leon Varjabedian et al. American Journal of Cardiovascular Drugs
- Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study
- (2018) Cheng-Wei Chan et al. Cardiovascular Diabetology
- The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial
- (2018) Fiona J. Dore et al. Cardiovascular Diabetology
- Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
- (2018) Mariël F. van Stee et al. Cardiovascular Diabetology
- Repurposing Metformin for Cardiovascular Disease
- (2018) Graham Rena et al. CIRCULATION
- Metformin, lipids and atherosclerosis prevention
- (2018) Alicia J. Jenkins et al. CURRENT OPINION IN LIPIDOLOGY
- All-cause and cardiovascular mortality associated with sulphonylurea and metformin therapy in type 2 diabetes
- (2018) Sorin Ioacara et al. ENDOCRINE RESEARCH
- Metformin as first-line treatment for type 2 diabetes
- (2018) Suetonia C Palmer et al. LANCET
- Efficacy of metformin in the management of periodontitis: A systematic review and meta-analysis
- (2018) Shariq Najeeb et al. SAUDI PHARMACEUTICAL JOURNAL
- Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease
- (2018) Naim Shehadeh et al. Cardiovascular Diabetology
- The influence of metformin and the presence of type 2 diabetes mellitus on mortality and hospitalisation in patients with heart failure
- (2018) Arkadiusz Retwiński et al. Kardiologia Polska
- Metformin induces significant reduction of body weight, total cholesterol and LDL levels in the elderly – A meta-analysis
- (2018) Margit Solymár et al. PLoS One
- Metformin and risk of long-term mortality following an admission for acute heart failure
- (2017) Lorenzo Fácila et al. Journal of Cardiovascular Medicine
- Differential effects of metformin on age related comorbidities in older men with type 2 diabetes
- (2017) Chen-Pin Wang et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Liraglutide and Metformin alone or combined therapy for type 2 diabetes patients complicated with coronary artery disease
- (2017) Ying Liu et al. Lipids in Health and Disease
- Combination therapy of metformin plus dipeptidyl peptidase-4 inhibitor versus metformin plus sulfonylurea and their association with a decreased risk of cardiovascular disease in type 2 diabetes mellitus patients
- (2017) Fei Wang et al. MEDICINE
- Combined use of metformin and atorvastatin attenuates atherosclerosis in rabbits fed a high-cholesterol diet
- (2017) Fei Luo et al. Scientific Reports
- Protocol for a randomised controlled trial of the effect of dapagliflozin, metformin and exercise on glycaemic variability, body composition and cardiovascular risk in prediabetes (the PRE-D Trial)
- (2017) Kristine Færch et al. BMJ Open
- Comparative Safety of Sulfonylurea and Metformin Monotherapy on the Risk of Heart Failure: A Cohort Study
- (2017) Christianne L. Roumie et al. Journal of the American Heart Association
- Protective Effect of Metformin on Myocardial Injury in Metabolic Syndrome Patients following Percutaneous Coronary Intervention
- (2017) Jing Li et al. CARDIOLOGY
- Comparative effectiveness of oral antidiabetic drugs in preventing cardiovascular mortality and morbidity: A network meta-analysis
- (2017) Gyeongsil Lee et al. PLoS One
- Safety of Concomitant Metformin and Proton Pump Inhibitor Use: A Population Retrospective Cohort Study
- (2016) Christopher B. Chen et al. CLINICAL THERAPEUTICS
- Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles
- (2016) Raphael Wurm et al. HEART
- Metformin and contrast-induced acute kidney injury in diabetic patients treated with primary percutaneous coronary intervention for ST segment elevation myocardial infarction: Amulticenter study
- (2016) Marianne Zeller et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Statin and Metformin Use Prolongs Survival in Patients With Resectable Pancreatic Cancer
- (2016) Margaret M. Kozak et al. PANCREAS
- The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction
- (2016) Lawien Al Ali et al. PLoS One
- Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial
- (2016) Ruben N. Eppinga et al. PLoS One
- Differential associations of circulating asymmetric dimethylarginine and cell adhesion molecules with metformin use in patients with type 2 diabetes mellitus and stable coronary artery disease
- (2015) Olga Kruszelnicka et al. AMINO ACIDS
- Effect of metformin monotherapy on cardiovascular diseases and mortality: a retrospective cohort study on Chinese type 2 diabetes mellitus patients
- (2015) Colman Siu Cheung Fung et al. Cardiovascular Diabetology
- The Effect of Metformin Use on Left Ventricular Ejection Fraction and Mortality Post-Myocardial Infarction
- (2015) Amjad Abualsuod et al. CARDIOVASCULAR DRUGS AND THERAPY
- Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational study
- (2014) C. Ll. Morgan et al. DIABETES OBESITY & METABOLISM
- Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls
- (2014) C. A. Bannister et al. DIABETES OBESITY & METABOLISM
- Effect of Metformin on Left Ventricular Function After Acute Myocardial Infarction in Patients Without Diabetes
- (2014) Chris P. H. Lexis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes
- (2014) Rury R Holman et al. LANCET
- Comparative Effectiveness of Sulfonylurea and Metformin Monotherapy on Cardiovascular Events in Type 2 Diabetes Mellitus
- (2013) Christianne L. Roumie et al. ANNALS OF INTERNAL MEDICINE
- Chronic Metformin Treatment is Associated with Reduced Myocardial Infarct Size in Diabetic Patients with ST-segment Elevation Myocardial Infarction
- (2013) Chris P. H. Lexis et al. CARDIOVASCULAR DRUGS AND THERAPY
- All-cause mortality and cardiovascular effects associated with the DPP-IV inhibitor sitagliptin compared with metformin, a retrospective cohort study on the Danish population
- (2013) N. M. Scheller et al. DIABETES OBESITY & METABOLISM
- Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial
- (2013) David Preiss et al. Lancet Diabetes & Endocrinology
- Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial
- (2012) Chris P. H. Lexis et al. CARDIOVASCULAR DRUGS AND THERAPY
- Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease
- (2012) J. Hong et al. DIABETES CARE
- Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis
- (2012) K. M. Pantalone et al. DIABETES OBESITY & METABOLISM
- The effect of metformin on insulin resistance and exercise parameters in patients with heart failure
- (2012) Aaron K.F. Wong et al. EUROPEAN JOURNAL OF HEART FAILURE
- Chronic Pretreatment of Metformin is Associated with the Reduction of the No-Reflow Phenomenon in Patients with Diabetes Mellitus After Primary Angioplasty for Acute Myocardial Infarction
- (2011) Jing-Lin Zhao et al. Cardiovascular Therapeutics
- Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin–Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study
- (2011) L. G. Mellbin et al. DIABETOLOGIA
- Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study
- (2011) Tina Ken Schramm et al. EUROPEAN HEART JOURNAL
- Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community
- (2011) Sotero P. Romero et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Metformin Use and Mortality Among Patients With Diabetes and AtherothrombosisMetformin Use With Diabetes and Atherothrombosis
- (2010) Ronan Roussel ARCHIVES OF INTERNAL MEDICINE
- Sulphonylurea-metformin combination therapy, cardiovascular disease and all-cause mortality: the Fremantle Diabetes Study
- (2010) B. Sillars et al. DIABETES OBESITY & METABOLISM
- The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis
- (2009) Kevin M. Pantalone et al. ACTA DIABETOLOGICA
- Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus
- (2009) Adriaan Kooy et al. ARCHIVES OF INTERNAL MEDICINE
- Metformin Therapy and Outcomes in Patients With Advanced Systolic Heart Failure and Diabetes
- (2009) Digish D. Shah et al. JOURNAL OF CARDIAC FAILURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now